The 2021 Consolidated Financial Statements
approved by the board of directors
Date of events
2022/03/31
To which item it meets
paragraph 31
Statement
1.Date of submission to the board of directors or approval by the board of
directors:2022/03/31
2.Date of approval by the audit committee:2022/03/31
3.Start and end dates of financial reports or annual self-assessed
financialof the reporting period (XXXX/XX/XX~XXXX/XX/XX):
2021/01/01~2021/12/31
4.Revenues accumulated from 1/1 to end of the period
(thousand NTD):188,373,202.
5.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):646,215.
6.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):2,611,988.
7.Profit (loss) during the period attributable to
owners of parent accumulated from 1/1 to end of the period
(thousand NTD):1,890,261.
8.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):2.19.
9.Total assets end of the reporting period (thousand NTD):1,427,046,503.
10.Total liabilities end of the reporting period (thousand NTD):
1,379,820,711.
11.Equity attributable to owners of parent end of the
reporting period (thousand NTD):19,720,837.
12.Any other matters that need to be specified:None.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Mercuries & Associates Holding Ltd. published this content on 31 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 31 March 2022 07:35:05 UTC.
MERCURIES & ASSOCIATES, HOLDINGS LTD. is a Taiwan-based investment holding company principally engaged in life insurance businesses. The Company operates through four businesses. The Retail of Daily Commodities and Food businesses include the trading of garments, accessories, toys, medical supplies, infant products, jewelries, glasses and porcelains, as well as the provision of fast food. The Life Insurance businesses include personal insurance, personal health insurance, personal accident insurance, personal pension insurance and group insurance, among others. Pharmaceuticals businesses include the manufacture of active pharmaceutical ingredients (API), API intermediates and specialized chemicals. Other businesses include financial businesses, system integration businesses and engineering repair and maintenance businesses, among others.